Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec;10(12):835-836.
doi: 10.1016/S2213-8587(22)00283-2. Epub 2022 Oct 14.

Open-source automated insulin delivery in type 1 diabetes-the evidence is out there

Sufyan Hussain  1 , Rayhan A Lal  2 , Katarina Braune  3
Affiliations
Comment

Open-source automated insulin delivery in type 1 diabetes-the evidence is out there

Sufyan Hussain et al. Lancet Diabetes Endocrinol. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

In addition to their professional roles, SH, RAL, and KB have personal experience of using open-source AID systems. SH reports personal fees from Novo Nordisk, outside the submitted work. RAL reports personal fees from Abbott Diabetes Care, Bioling, Capillary Biomedical, Deep Valley Labs, Gluroo, Provention Bio, and Tidepool, outside the submitted work. KB reports personal fees from Sanofi Diabetes, Medtronic Diabetes, Dexcom, Roche Diabetes Care, Diabetes Center Berne, Lillu, Diabeloop, Abbott, Novo Nordisk, and Dedoc Labs. SH is a recipient of the Medical Research Council Clinical Academic Partnership award. RAL is supported by a Diabetes, Endocrinology and Metabolism Career Development grant (1K23DK122017) from the National Institute of Diabetes and Digestive and Kidney Diseases and co-leads the Bioengineering and Behavioral Sciences working group for the Stanford Diabetes Research Center (P30 DK116074); he has additional research support from JDRF, Medtronic and Insulet. KB is supported by the Digital Clinician Scientist programme of Charité Universitätsmedizin Berlin and the Berlin Institute of Health. No specific funding has been received related to the publication of this article.

Comment on

  • Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    Burnside MJ, Lewis DM, Crocket HR, Meier RA, Williman JA, Sanders OJ, Jefferies CA, Faherty AM, Paul RG, Lever CS, Price SKJ, Frewen CM, Jones SD, Gunn TC, Lampey C, Wheeler BJ, de Bock MI. Burnside MJ, et al. N Engl J Med. 2022 Sep 8;387(10):869-881. doi: 10.1056/NEJMoa2203913. N Engl J Med. 2022. PMID: 36069869 Clinical Trial.

References

    1. Braune K, Lal RA, Petruželková L, et al. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 2022; 10: 58–74. - PMC - PubMed
    1. Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery (AID) technologies in clinical practice. Endocr Rev 2022; published online Sept 6. 10.1210/endrev/bnac022. - DOI - PMC - PubMed
    1. Burnside M, Crocket H, Mayo M, Pickering J, Tappe A, de Bock M. Do-it-yourself automated insulin delivery: a leading example of the democratization of medicine. J Diabetes Sci Technol 2020; 14: 878–82. - PMC - PubMed
    1. Knoll C, Peacock S, Wäldchen M, et al. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: a systematic review. Diabet Med 2022; 39: e14741. - PubMed
    1. Freckmann G, Mende J. Continuous glucose monitoring: data management and evaluation by patients and health care professionals—current situation and developments. J Lab Med 2018; 42: 225–33.